These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23965)

  • 1. Acetylcholine--inhibition of transmitter release from adrenergic nerve terminals mediated by muscarinic receptors.
    Shepherd JT; Lorenz RR; Tyce GM; Vanhoutte PM
    Fed Proc; 1978 Feb; 37(2):191-4. PubMed ID: 23965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein.
    O'Rourke ST; Vanhoutte PM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):64-7. PubMed ID: 3572796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibilities for a cholinergic action on smooth musculature and on sympathetic axons in brain vessels mediated by muscarinic and nicotinic receptors.
    Edvinsson L; Falck B; Owman C
    J Pharmacol Exp Ther; 1977 Jan; 200(1):117-26. PubMed ID: 833753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic inhibition of adrenergic transmission.
    Vanhoutte PM
    Fed Proc; 1977 Sep; 36(10):2444-9. PubMed ID: 196943
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence that halothane inhibits norepinephrine release from sympathetic nerve endings in dog saphenous vein by stimulation of presynaptic inhibitory muscarinic receptors.
    Rorie DK; Tyce GM; Mackenzie RA
    Anesth Analg; 1984 Dec; 63(12):1059-64. PubMed ID: 6507906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine and 5-hydroxytryptamine-inhibition of transmitter release mediated by H2- and 5-hydroxytryptamine receptors.
    McGrath MA; Shepherd JT
    Fed Proc; 1978 Feb; 37(2):195-8. PubMed ID: 23966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of norepinephrine- 3 H release from sympathetic nerve endings in veins by acetylcholine.
    Vanhoutte PM; Lorenz RR; Tyce GM
    J Pharmacol Exp Ther; 1973 May; 185(2):386-94. PubMed ID: 4703828
    [No Abstract]   [Full Text] [Related]  

  • 8. Gallamine and pancuronium inhibit pre- and postjunctional muscarine receptors in canine saphenous veins.
    Vercruysse P; Bossuyt P; Hanegreefs G; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1979 May; 209(2):225-30. PubMed ID: 438998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prejunctional and postjunctional effects of acetylcholine in the blood vessel wall.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1982; 44(5-6):269-94. PubMed ID: 6306945
    [No Abstract]   [Full Text] [Related]  

  • 11. The inhibition of norepinephrine release in nasal mucosa by acetylcholine.
    Jackson RT; Steele RW
    Rhinology; 1985 Mar; 23(1):59-64. PubMed ID: 4001760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the tricyclic antidepressant amitriptyline with prejunctional alpha and muscarinic receptors in the dog saphenous vein.
    Collis MG; Shepherd JT
    J Pharmacol Exp Ther; 1980 Jun; 213(3):616-22. PubMed ID: 6259320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High spatial resolution studies of muscarinic neuroeffector junctions in mouse isolated vas deferens.
    Cuprian-Beltechi AM; Solanki P; Teramoto N; Cunnane TC
    Neuroscience; 2009 Sep; 162(4):1366-76. PubMed ID: 19486927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by acetylcholine of the norepinephrine release evoked by potassium in canine saphenous veins.
    Vanhoutee PM; Verbeuren TJ
    Circ Res; 1976 Aug; 39(2):263-9. PubMed ID: 939012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
    Raiteri M; Bonanno G; Marchi M; Maura G
    J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenic cholinergic prejunctional inhibition of sympathetic beta adrenergic relaxation in the canine coronary artery.
    Cohen RA; Shepherd JT; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 May; 229(2):417-21. PubMed ID: 6325664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of norepinephrine release in vascular smooth muscle by acetycholine. Due to hyperpolarization of adrenergic nerve endings?
    Vanhoutte PM; Verbeuren TJ
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):332-3. PubMed ID: 1147725
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on modulation of transmitter release and effector responsiveness in autonomic cholinergic neurotransmission.
    Gustafsson LE
    Acta Physiol Scand Suppl; 1980; 489():1-28. PubMed ID: 6109427
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of transmitter release from the locust forewing stretch receptor neuron by GABAergic interneurons activated via muscarinic receptors.
    Judge S; Leitch B
    J Neurobiol; 1999 Sep; 40(3):420-31. PubMed ID: 10440741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral muscarinic control of norepinephrine release in the cardiovascular system.
    Muscholl E
    Am J Physiol; 1980 Dec; 239(6):H713-20. PubMed ID: 7192494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.